Group 3 innate lymphoid cells mediate early protective immunity against TB

27 Jun 2019
27 Jun 2019

Dr William Horsnell and Dr Matthew Darby of the Division of Immunology recently co-authored a paper entitled “Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis” published in Nature.

The researchers investigated innate lymphoid cells (ILCs) in immune responses to infection with Mycobacterium tuberculosis (Mtb). In the study they showed that ILCs are activated and recruited to the human lung during infection with Mtb. It therefore follows that the ILCs participate in immunity to Tuberculosis (TB).

Multiple mouse models were used to illustrate the importance of ILC3s to the outcome of infection – a reduction  in lung ILC3s weakened early immune control of Mtb. As there were more Mtb bacteria in the lung the was a coinciding decrease in IL-17 and IL-22 production, “compromised alveolar macrophage accumulation and impaired iBALT organization, which was dependent on the CXCR5–CXCL13 axis—which are key aspects of the immune response to Mtb”.

Dr William Horsnell and Dr Matthew Darby and their colleagues have therefore demonstrated an early protective role for ILC3s in immunity to Mtb infection.

Read the paper - Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis

Article by Bonamy Holtak